The emerging role of psilocybin and MDMA in the treatment of mental illness
Expert Review of Neurotherapeutics September 21, 2020 Hartej Gill, Barjot Gill, David C J Chen-Li et al. 62 citations
Psychedelics, such as psilocybin and MDMA, offer an alternative avenue of therapy for many mental health disorders. Available evidence indicates that psychedelics may offer a single-dose, rapid effect model that have robust effects with treatment-resistant mental disorders and a unique advantage as a possible monotherapy for mental illness. Novel clinical trials that evaluate the safety,...
DOI: 10.1080/14737175.2020.1826931 (opens in new tab)
Psilocybin
MDMA
Mental illness
Mental health
+3